miR-154 suppresses colorectal cancer cell growth and motility by targeting TLR2. (Q39062255)

8 September 2017

miR-154 suppresses colorectal cancer cell growth and motility by targeting TLR2. (English)

1 reference

8 September 2017

0 references

1 reference

1 reference

1 reference

Chaoguang Xin

1

1 reference

PubMed ID

24242044

8 September 2017

Hao Zhang

series ordinal

2

1 reference

PubMed ID

24242044

8 September 2017

Zanchao Liu

series ordinal

3

1 reference

8 September 2017

16 November 2013

1 reference

Molecular and Cellular Biochemistry

8 September 2017

1 reference

8 September 2017

387

1 reference

8 September 2017

1-2

1 reference

8 September 2017

271-277

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-013-1892-3

8 September 2017

0 references

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

MicroRNAs (miRNAs) in colorectal cancer: from aberrant expression towards therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

The nuclear RNase III Drosha initiates microRNA processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

The core microprocessor component DiGeorge syndrome critical region 8 (DGCR8) is a nonspecific RNA-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

Role of Intracellular and Extracellular MicroRNA-92a in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

miR-154 inhibits EMT by targeting HMGA2 in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

Human tumor microRNA signatures derived from large-scale oligonucleotide microarray datasets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

Toll-like receptor regulation of effector T lymphocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

DAMPening inflammation by modulating TLR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

Species-specific PAMP recognition by TLR2 and evidence for species-restricted interaction with Dectin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

The regulation of Toll-like receptor 2 by miR-143 suppresses the invasion and migration of a subset of human colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

Blocking TLR2 activity attenuates pulmonary metastases of tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

TLR signaling by tumor and immune cells: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1892-3

Association of TLR2, TLR3, TLR4 and CD14 genes polymorphisms with oral cancer risk and survival

21 January 2018

1 reference

12 December 2020

Contribution of surgical specialization to improved colorectal cancer survival

1 reference

12 December 2020

MicroRNA-124 regulates the proliferation of colorectal cancer cells by targeting iASPP.

1 reference

12 December 2020

Upregulation of microRNA-155 promotes the migration and invasion of colorectal cancer cells through the regulation of claudin-1 expression

1 reference

12 December 2020

Current management of peritoneal carcinomatosis from colorectal cancer

1 reference

12 December 2020

miR-154 inhibits prostate cancer cell proliferation by targeting CCND2.

1 reference

12 December 2020

Differential role of MyD88 and Mal/TIRAP in TLR2-mediated gastric tumourigenesis.

1 reference

12 December 2020

10.1007/S11010-013-1892-3

Identifiers

DOI

1 reference

8 September 2017

1 reference

PubMed ID

24242044